I'm first person to have proton therapy in the UK
THE first indication there was something wrong came last summer when Simon Hardacre began to feel stressed and run down. Like many men he was inclined to attribute his condition to the wear and tear of life but after encouragement from partner Maria Kose, 40, he went to see a GP. (Source: Daily Express - Health)
Source: Daily Express - Health - July 11, 2018 Category: Consumer Health News Source Type: news
Proton therapy ‘miracle’ treatment allows girl who was blind in one eye to see again
A LITTLE girl who was blinded in one eye has stunned doctors to see again - thanks to miracle treatment in the USA. (Source: Daily Express - Health)
Source: Daily Express - Health - June 29, 2018 Category: Consumer Health News Source Type: news
Latest Evidence for Particle Therapy in NSCLC Latest Evidence for Particle Therapy in NSCLC
What is the latest evidence on proton therapy for locally advanced lung cancer?Translational Lung Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 25, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Mevion secures $150M in financing
Mevion Medical Systems has secured $150 million in financing in a deal...Read more on AuntMinnie.comRelated Reading:
Mevion treats 1st patient with proton therapy system
Mevion nabs FDA OK for proton therapy system
Mevion submits 510(k) to FDA for proton therapy system
Mevion touts scanning milestone
Mevion joins forces with MedPhoton (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 14, 2018 Category: Radiology Source Type: news
Mevion Medical closes $150m funding round
Mevion Medical Systems said today it closed a $150 million financing round with funds slated to support the company’s proton therapy devices and to expand manufacturing.
The round was led by YuanMing Capital and joined by Henan Maisheng Medical Technology and existing investors including HOPU Investments and China Everbright Limited, the Littleton, Mass.-based company said.
Mevion said that funding would be used to support its proton therapy business and to expand the company’s manufacturing capabilities to meet an increased interest in its Hyperscan systems.
Funding will also support the company’s expans...
Source: Mass Device - June 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Funding Roundup Wall Street Beat Mevion Medical Systems Source Type: news
Varian Acquires Taiwan Distributor
PALO ALTO, Calif. and TAIPEI, Taiwan, May 7, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced it has acquired Cooperative CL Enterprises (COOP), a leading distributor of radiotherapy equipment in Taiwan. COOP currentl... Devices, Oncology, Distribution, Mergers & Acquisitions Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 7, 2018 Category: Pharmaceuticals Source Type: news
Governor vetoes bill that would have benefited new Franklin cancer center
Gov. Bill Haslam has vetoed a bill that would have aided a cancer treatment center being constructed in Middle Tennessee.
The bill, which passed the House by a vote of 82-13 and by a 29-1 vote in the Senate, would have required insurance coverage of proton cancer therapy for state employees.
The veto comes as the construction of a $100 million cancer-treatment center by Provision CARES Proton Therapy nears completio n in Franklin. It will be the second center for Knoxville-based Provision CARES,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 3, 2018 Category: Pharmaceuticals Authors: Joel Stinnett Source Type: news
Boom in proton therapy is a bust for some. Blame a shortage of patients.
But about 30 years after the Food and Drug Administration first approved proton therapy for limited uses, doctors often hesitate to prescribe it and insurers often will not cover it. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 30, 2018 Category: American Health Authors: Jay Hancock Source Type: news
For Cancer Centers, Proton Therapy ’ s Promise Is Undercut by Lagging Demand
Hospitals and private investors keep pumping vast sums of money into an advanced type of radiology whose effectiveness, in many cases, has not yet been shown to justify its price. (Source: NYT Health)
Source: NYT Health - April 27, 2018 Category: Consumer Health News Authors: JAY HANCOCK Tags: Health Insurance and Managed Care Prostate Cancer Radiation Particle Accelerators Law and Legislation Emanuel, Ezekiel J Food and Drug Administration Georgetown University University of Maryland Medical Center Memorial Sloan-Kettering Ca Source Type: news
Varian posts Q2 revenue increase
Revenue growth in its Oncology Systems business propelled radiation oncology...Read more on AuntMinnie.comRelated Reading:
Varian releases Halcyon updates
Varian releases new version of Velocity
Brainlab, Varian team up on product integrations
Varian bid for Sirtex clears regulatory hurdle
Varian touts proton therapy educational milestone (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 26, 2018 Category: Radiology Source Type: news
Varian releases Halcyon updates
Varian Medical Systems has released updates to its Halcyon radiation therapy...Read more on AuntMinnie.comRelated Reading:
Varian releases new version of Velocity
Brainlab, Varian team up on product integrations
Varian bid for Sirtex clears regulatory hurdle
Varian touts proton therapy educational milestone
Varian acquires decision-support firm (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 19, 2018 Category: Radiology Source Type: news
Engineering during the “Fuzzy Front End” of Development
What’s the “fuzzy front end”? It’s the phase between first consideration of an opportunity and when it’s deemed ready to enter a structured development process. A common characteristic of the “fuzzy front end” is the desire to create and evaluate multiple concept alternatives on the road to selecting a single preferred approach.
It’s pursuing multiple concepts that often pose a special chicken-or-the-egg challenge for engineering because you:
Don’t have a complete design to assess feasibility.
Can’t fully assess feasibility without a complete design.
This dilemma means engineers must thoughtfully ass...
Source: MDDI - April 10, 2018 Category: Medical Devices Authors: Dave Franchino Tags: BIOMEDevice Boston Design Source Type: news
Varian releases new version of Velocity
Varian Medical Systems has released a new version of its Velocity cancer imaging...Read more on AuntMinnie.comRelated Reading:
Brainlab, Varian team up on product integrations
Varian bid for Sirtex clears regulatory hurdle
Varian touts proton therapy educational milestone
Varian acquires decision-support firm
India clears Varian's Halcyon radiation therapy system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 9, 2018 Category: Radiology Source Type: news
Brainlab, Varian team up on product integrations
Image-guided therapy firm Brainlab has signed a deal with Varian Medical Systems...Read more on AuntMinnie.comRelated Reading:
Varian bid for Sirtex clears regulatory hurdle
Varian touts proton therapy educational milestone
Varian acquires decision-support firm
Brainlab gets FDA nod for MR contrast analysis software
FDA clears 2 Brainlab software applications
Brainlab ships planning software package (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 3, 2018 Category: Radiology Source Type: news
Mevion touts first use of S250i proton therapy system
Mevion Medical Systems today announced the launch of its Mevion S250i proton therapy system, touting that the first patient in the world had been treated with the system.
The Mevion S250i features improved pencil beam scanning fields and Hyperscan pencil beam scanning tech to allow for faster energy layer switching, the Littleton, Mass.-based company said.
The system also features the company’s Adaptive Aperture multi-leaf collimator designed for multi-layer conformal field delivery, Mevion said, which it claims provides dose gradients with up to 3 times sharper lateral penumbra.
“The launch of the Hyperscan syste...
Source: Mass Device - April 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Oncology Mevion Medical Systems Source Type: news
